About MicroSure
MicroSure is a company based in Eindhoven (Netherlands) founded in 2014. MicroSure has raised $43.05 million across 4 funding rounds from investors including European Union, BOM and TU Eindhoven. MicroSure offers products and services including MUSA-3 and MUSA-2. MicroSure operates in a competitive market with competitors including Intuitive, Auris Health, Corindus Vascular Robotics, Brainlab and PROCEPT BioRobotics, among others.
- Headquarter Eindhoven, Netherlands
-
Sectors
HealthcareIndustrial Goods & Manufacturing
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Microsure B.V.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$43.05 M (USD)
in 4 rounds
-
Latest Funding Round
$39.79 M (USD), Series B
Oct 04, 2023
-
Investors
European Union
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MicroSure
MicroSure offers a comprehensive portfolio of products and services, including MUSA-3 and MUSA-2.
Provides precise, tremor-filtered movements for advanced surgical procedures.
Enables high-precision operations on small structures using existing instruments.
People of MicroSure
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of MicroSure
MicroSure has successfully raised a total of $43.05M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $39.79 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $39.8M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Series B - MicroSure | Valuation | Invest-NL , European Union | |
| Jan, 2022 | Amount | Grant - MicroSure | Valuation |
investors |
|
| Apr, 2021 | Amount | Series B - MicroSure | Valuation | Invest-NL |
Investors in MicroSure
MicroSure has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, BOM and TU Eindhoven.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Infrastructure and venture capital funding is provided in key sectors.
|
Founded Year | Domain | Location | |
|
A European venture capital fund focused on deep tech investments.
|
Founded Year | Domain | Location | |
|
Investments are directed by BOM toward early and growth-stage firms.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MicroSure
Financial Statements - MicroSure
Microsure Comparisons
Competitors of MicroSure
MicroSure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intuitive, Auris Health, Corindus Vascular Robotics, Brainlab and PROCEPT BioRobotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Robotic-assisted surgical systems are developed for minimally invasive procedures.
|
|
| domain | founded_year | HQ Location |
Robotic microsurgical systems for endoscopy are developed.
|
|
| domain | founded_year | HQ Location |
Remote robotic systems for vascular interventional procedures are developed.
|
|
| domain | founded_year | HQ Location |
Software and integrated solutions for surgical and radiotherapy applications
|
|
| domain | founded_year | HQ Location |
Robotic waterjet system for prostate tissue removal is developed.
|
|
| domain | founded_year | HQ Location |
Robotic guidance systems for spine surgery are manufactured and utilized.
|
Frequently Asked Questions about MicroSure
MicroSure was founded in 2014 and raised its 1st funding round 4 years after it was founded.
MicroSure is headquartered in Eindhoven, Netherlands. It is registered at Eindhoven, Noord-brabant, Netherlands.
Iwan van Vijfeijken is the current CEO of MicroSure.
MicroSure is a funded company, having raised a total of $43.05M across 4 funding rounds to date. The company's 1st funding round was a Series B of $3.26M, raised on Mar 29, 2018.
Developer of robotic solutions to advance microsurgery. The flagship product, MUSA, is a microsurgical robot designed to assist microsurgeons in complex procedures. Mus3 consists of a surgeon console and robotic arm cart which is combined with a separate digital or hybrid microscope.
MicroSure's top competitors include Brainlab, PROCEPT BioRobotics and Auris Health.
MicroSure offers MUSA-3 and MUSA-2.
MicroSure has 8 investors. Key investors include European Union, BOM, TU Eindhoven, Invest-NL, and kineo finance.